As the nonsevere patients exhibited this thromboelastometric parameter (NATEM-CT) suggestive of incipient hypercoagulopathy, our results suggested that even patients not hospitalized with nonsevere forms of COVID-19 may present a risk of developing thromboembolic events, which is probably due to increased levels of circulating TF expression. The gene discussed is TF; the disease is COVID-19.